| Interactions between Xenobiotics and DME (XEOTIC)
|
| Health or Environmental Toxicant(s) |
| Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Benzo(a)pyrene |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen |
| DME Modulation |
Benzo(a)pyrene up-regulates the expression of DME SULT1A3 |
[1] |
| Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Diethylhexyl phthalate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01004
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
Diethylhexyl phthalate up-regulates the expression of DME SULT1A3 |
[2] |
| Glycidamide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01009
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
Glycidamide up-regulates the expression of DME SULT1A3 |
[3] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Amiodarone hydrochloride |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00277
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Amiodarone hydrochloride up-regulates the expression of DME SULT1A3 |
[4] |
| Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Ethanol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00539
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Ethanol inhibits the drug-metabolizing activity of DME SULT1A3 |
[5] |
|
|
|
|
|
|